Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) - Trial NCT01146444
Access comprehensive clinical trial information for NCT01146444 through Pure Global AI's free database. This phase not specified trial is sponsored by Spirig Pharma Ltd. and is currently Completed. The study focuses on Cutaneous Lupus Erythematosus. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Spirig Pharma Ltd.
Timeline & Enrollment
N/A
Nov 01, 2009
Nov 01, 2012
Primary Outcome
Prevention of skin lesions following standardized photoprovokation with UVA/UVB light in patients with CLE
Summary
Part I: to investigate the efficacy of different sunscreens in the prevention of skin lesions
 following standardized photoprovocation with Ultraviolet A/Ultraviolet B (UVA/UVB) light in
 patients with CLE.
 
 Part II: to evaluate the influence of different sunscreens on the expression of biomarkers in
 the skin of patients with CLE and of Healthy Controls following UV irradiation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01146444
Non-Device Trial